Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.
Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.
复制标题
DOI:
10.1038/s41388-019-0797-3
复制
发表时间:
2019-05
期刊:
影响因子:
8
通讯作者:
Spiegelman VS
中科院分区:
文献类型:
--
作者:
Ghoshal A;Rodrigues LC;Gowda CP;Elcheva IA;Liu Z;Abraham T;Spiegelman VS
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is a multifunctional RNA-binding protein with an oncofetal pattern of expression shown to be implicated in the development of a variety of malignancies. In this study, we explored the role and mechanisms of IGF2BP1 in melanoma development and progression. In two different in vivo models, we showed that while genetic deletion or shRNA-mediated suppression of IGF2BP1 did not affect primary tumor formation, it drastically suppressed lung metastasis. Here we demonstrated that extracellular vesicles (EVs) secreted by melanoma cells mediate the effects of IGF2BP1 on metastasis: EVs from the IGF2BP1 knockdown melanoma cells failed to promote metastasis whereas EVs isolated from IGF2BP1-overexpressed melanoma cells further accelerated EV-induced metastasis. Moreover, the EVs from IGF2BP1 knockdown melanoma cells inhibited fibronectin deposition and accumulation of CD45+ cells in the lungs compared to control EVs, thus blocking the pre-metastatic niche formation potential of EVs. IGF2BP1 knockdown did not affect size, number, or protein/RNA concentration of secreted EVs or their uptake by recipient cells in vitro or in vivo. However, RNA-sequencing and proteomics analysis of the EVs revealed differential expression in a number of mRNA, proteins and miRNAs. This suggested that IGF2BP1 is intimately involved in the regulation of the cargo of EVs, thereby affecting the pro-metastatic function of melanoma-derived EVs. To the best of our knowledge, this is the first study that demonstrates the role of RNA-binding protein IGF2BP1 in EV-mediated promotion of melanoma metastasis and may provide novel avenues for the development of metastatic inhibitors.
登录
查看更多内容
影响因子:
7.5
作者:
Gupta S;Rawat S;Arora V;Kottarath SK;Dinda AK;Vaishnav PK;Nayak B;Mohanty S
通讯作者:
Mohanty S
影响因子:
4.3
作者:
Iyer, Soumya C.;Gopal, Ashidha;Halagowder, Devaraj
通讯作者:
Halagowder, Devaraj
影响因子:
21.3
作者:
Costa-Silva B;Aiello NM;Ocean AJ;Singh S;Zhang H;Thakur BK;Becker A;Hoshino A;Mark MT;Molina H;Xiang J;Zhang T;Theilen TM;García-Santos G;Williams C;Ararso Y;Huang Y;Rodrigues G;Shen TL;Labori KJ;Lothe IM;Kure EH;Hernandez J;Doussot A;Ebbesen SH;Grandgenett PM;Hollingsworth MA;Jain M;Mallya K;Batra SK;Jarnagin WR;Schwartz RE;Matei I;Peinado H;Stanger BZ;Bromberg J;Lyden D
通讯作者:
Lyden D
影响因子:
8
作者:
Chen Y;Zeng C;Zhan Y;Wang H;Jiang X;Li W
通讯作者:
Li W
影响因子:
2.8
作者:
Li, Wenhai;Hu, Yunsheng;Li, Xiaofei
通讯作者:
Li, Xiaofei